Estrogen dose in oral contraceptives FDA committee examines safety and utility of 50 mcg estrogen OCs

Estrogen dose in oral contraceptives : FDA committee examines safety and utility of 50 mcg estrogen OCs

Bibliographische Detailangaben
Veröffentlicht in:Contraception Report. - 1993. - 5(1994), 1 vom: 18. März, Seite 10-3
Format: Aufsatz
Sprache:English
Veröffentlicht: 1994
Zugriff auf das übergeordnete Werk:Contraception Report
Schlagworte:Journal Article Age Factors Americas Contraception Contraceptive Agents, Estrogen--administraction and dosage Contraceptive Agents, Female--administraction and dosage Contraceptive Agents--administraction and dosage Contraceptive Methods Demographic Factors Developed Countries mehr... Diseases Drug Interactions Drugs Economic Factors Embolism Family Planning Health Marketing North America Northern America Oral Contraceptives Oral Contraceptives, Combined Packaging Population Population Characteristics Public Health Recommendations Safety Thromboembolism Treatment United States Vascular Diseases Contraceptive Agents Contraceptive Agents, Female Contraceptives, Oral Contraceptives, Oral, Combined Contraceptives, Oral, Hormonal Pharmaceutical Preparations
LEADER 01000naa a22002652 4500
001 NLM121159787
003 DE-627
005 20231222192446.0
007 tu
008 231222s1994 xx ||||| 00| ||eng c
028 5 2 |a pubmed24n0404.xml 
035 |a (DE-627)NLM121159787 
035 |a (NLM)12287738 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
245 1 0 |a Estrogen dose in oral contraceptives  |b FDA committee examines safety and utility of 50 mcg estrogen OCs 
264 1 |c 1994 
336 |a Text  |b txt  |2 rdacontent 
337 |a ohne Hilfsmittel zu benutzen  |b n  |2 rdamedia 
338 |a Band  |b nc  |2 rdacarrier 
500 |a Date Completed 04.01.1995 
500 |a Date Revised 14.11.2003 
500 |a published: Print 
500 |a Citation Status MEDLINE 
650 4 |a Journal Article 
650 4 |a Age Factors 
650 4 |a Americas 
650 4 |a Contraception 
650 4 |a Contraceptive Agents, Estrogen--administraction and dosage 
650 4 |a Contraceptive Agents, Female--administraction and dosage 
650 4 |a Contraceptive Agents--administraction and dosage 
650 4 |a Contraceptive Methods 
650 4 |a Demographic Factors 
650 4 |a Developed Countries 
650 4 |a Diseases 
650 4 |a Drug Interactions 
650 4 |a Drugs 
650 4 |a Economic Factors 
650 4 |a Embolism 
650 4 |a Family Planning 
650 4 |a Health 
650 4 |a Marketing 
650 4 |a North America 
650 4 |a Northern America 
650 4 |a Oral Contraceptives 
650 4 |a Oral Contraceptives, Combined 
650 4 |a Packaging 
650 4 |a Population 
650 4 |a Population Characteristics 
650 4 |a Public Health 
650 4 |a Recommendations 
650 4 |a Safety 
650 4 |a Thromboembolism 
650 4 |a Treatment 
650 4 |a United States 
650 4 |a Vascular Diseases 
650 7 |a Contraceptive Agents  |2 NLM 
650 7 |a Contraceptive Agents, Female  |2 NLM 
650 7 |a Contraceptives, Oral  |2 NLM 
650 7 |a Contraceptives, Oral, Combined  |2 NLM 
650 7 |a Contraceptives, Oral, Hormonal  |2 NLM 
650 7 |a Pharmaceutical Preparations  |2 NLM 
773 0 8 |i Enthalten in  |t Contraception Report  |d 1993  |g 5(1994), 1 vom: 18. März, Seite 10-3  |w (DE-627)NLM09824602X  |7 nnns 
773 1 8 |g volume:5  |g year:1994  |g number:1  |g day:18  |g month:03  |g pages:10-3 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 5  |j 1994  |e 1  |b 18  |c 03  |h 10-3